News: CRISPR Takes on Diagnostics in the Wake of the Pandemic - CRISPR Medicine
The state of play in the field of CRISPR diagnostics has been changing rapidly. Here, Bryan DeChairo, CEO of Sherlock Biosciences, discusses the progress, challenges, and future of CRISPR diagnostics...